Google.org

Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Solstice is a company dedicated to making renewable energy accessible to all Americans through community-shared solar power. Founded in 2016 and headquartered in Cambridge, Massachusetts, Solstice provides comprehensive customer solutions for shared solar, including subscriber aggregation and management services aimed at solar developers, utilities, and other providers. By employing community organizing techniques along with its innovative online marketplace, Solstice aggregates consumer demand to facilitate the deployment of community solar projects. This approach enables renters and homeowners with non-optimal roofs to participate in solar energy, allowing them to save on utility bills without upfront costs. Solstice is driven by a commitment to energy equity, striving to ensure that affordable renewable energy is available to every household, regardless of income or credit status. The company has been recognized with multiple awards for its contributions to clean energy and entrepreneurship.

If a technical career is what you seek, Benjamin Franklin Institute of Technology (BFIT) provides you with the education you need to pursue your professional goals. For over a century, BFIT has been one of Boston’s top career colleges. The institute has helped students reach their potential through technical education programs in the following types of fields: * Automotive Technology * Computer Technologies * Electronics Engineering Technology * Mechanical Engineering Technology * Medical Electronics Engineering Technology * Ophthalmic Assisting The Academic Success Center at BFIT ensures that students are given the resources and tools they need to excel in their academics and training. Some of the services offered through the center include: academic advising, special accommodations, tutoring, and more. College life at BFIT is filled with exciting experiences. From dorm life and council leadership to community service and intramural sports, the school encourages students to get involved in extracurricular activities. Applicants who are interested in admissions to the school must submit Accuplacer test results, an application, recommendation letters, and official transcripts for review. The school will waive its enrollment fee for any admissions applications submitted online. Merit and need-based financial aid exists in many forms at BFIT for those who qualify and are looking for tuition assistance.

Delphia Therapeutics, headquartered in Boston, USA, is a biotechnology company focused on cancer therapeutics. It operates a laboratory dedicated to studying cancer-driving pathways and developing treatments that target and over-activate specific cancer-linked cell signaling, ultimately leading to the death of tumor cells.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Founded in 2016 and headquartered in Boston, Massachusetts, with a branch in Cambridge, United Kingdom, Cerevance utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, within mature human brain tissue. By leveraging a substantial repository of over 15,000 human brain samples, the company generates extensive expression and epigenetic data, guiding the identification of promising therapeutic targets. This approach aims to address the early onset of central nervous system diseases by revealing critical transcriptional and epigenetic differences within affected brain regions.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Nimbus Therapeutics, LLC is a biotechnology company based in Cambridge, Massachusetts, focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. Founded in 2009, the company utilizes a computational technology-driven approach to advance a pipeline of novel small-molecule therapeutics. Nimbus Therapeutics specializes in designing allosteric inhibitors, notably targeting Acetyl-CoA Carboxylase for conditions such as non-alcoholic steatohepatitis and hepatocellular carcinoma. The company has established strategic partnerships with organizations like Charles River Laboratories and Celgene Corporation to enhance its drug development efforts. In March 2015, Nimbus Discovery rebranded itself as Nimbus Therapeutics to better reflect its transition into a clinical-stage enterprise.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Founded in 2016 and headquartered in Boston, Massachusetts, with a branch in Cambridge, United Kingdom, Cerevance utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, within mature human brain tissue. By leveraging a substantial repository of over 15,000 human brain samples, the company generates extensive expression and epigenetic data, guiding the identification of promising therapeutic targets. This approach aims to address the early onset of central nervous system diseases by revealing critical transcriptional and epigenetic differences within affected brain regions.

Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Merlin Labs, established in 2018 and based in Boston, Massachusetts, is dedicated to developing autonomous flight technology for fixed-wing aircraft. The company's core product is an AI-powered aircraft autonomy system, akin to those used in driverless cars, designed to enable safe, unmanned transportation of goods and eventually people. Merlin Labs operates at the intersection of software, transportation, and information technology sectors.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

FYTO, Inc. is a company based in Cambridge, Massachusetts, founded in 2019, that specializes in the development of plant-based feed production systems. The firm focuses on creating nutrient-dense crops and innovative cultivation and harvesting systems designed to enhance agricultural quality and consistency. FYTO's offerings include a variety of agricultural products such as animal feed, fodder, plant-based proteins, nutritional supplements, and bio-fertilizers. By employing climate-friendly methodologies, the company aims to improve both the economic and environmental sustainability of agriculture, providing personalized solutions to farmers worldwide that promote ultra-high yields while minimizing resource requirements.

Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.

Celsius Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for patients suffering from cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a multidisciplinary approach, integrating the expertise of scientists, computational biologists, and clinicians. Celsius Therapeutics utilizes advanced techniques such as single-cell genomic analysis and machine learning to identify and develop innovative therapeutic solutions. By leveraging these cutting-edge technologies, the company aims to create life-changing medicines that address unmet medical needs.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

RightHand Robotics, Inc. is a manufacturer of robotic order-picking systems that streamline supply chain logistics for various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company specializes in robotic solutions that automatically grasp a wide variety of items from bins and cases. Its flagship products include the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor designed to enhance the robots' ability to handle items gently and correct errors. RightHand Robotics focuses on providing end-to-end solutions that simplify integration and adaptation to diverse customer workflows, ultimately reducing the costs associated with order fulfillment across sectors such as electronics, apparel, grocery, and pharmaceuticals.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, that specializes in providing automated testing services to software development teams. Founded in 2016, mabl focuses on integrating automated end-to-end testing within the continuous integration and continuous delivery (CI/CD) development lifecycle. The company's platform employs machine learning to automatically fix broken tests and identify regressions, offering features such as scriptless testing, test auto-healing, and machine-driven regression testing. By enabling faster and more reliable testing, mabl helps organizations enhance the quality of their applications and accelerate their innovation processes. Its unified platform allows users to create, execute, and maintain tests efficiently, ultimately supporting agile and DevOps methodologies.

RightHand Robotics, Inc. is a manufacturer of robotic order-picking systems that streamline supply chain logistics for various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company specializes in robotic solutions that automatically grasp a wide variety of items from bins and cases. Its flagship products include the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor designed to enhance the robots' ability to handle items gently and correct errors. RightHand Robotics focuses on providing end-to-end solutions that simplify integration and adaptation to diverse customer workflows, ultimately reducing the costs associated with order fulfillment across sectors such as electronics, apparel, grocery, and pharmaceuticals.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Ribon Therapeutics, Inc. is a biotechnology company founded in 2015 and headquartered in Lexington, Massachusetts. The company focuses on developing novel therapeutics that target monoPARP proteins, which are critical regulators of cancer cell survival mechanisms. By leveraging insights from its scientific founders, Ribon is establishing a proprietary drug discovery platform aimed at investigating the molecular actions and biological functions of a specific subset of the PARP protein family. This platform enables Ribon to create a pipeline of innovative small molecule inhibitors designed to disrupt the fundamental survival capabilities of cancer cells under stress. In addition to cancer treatment, the company's research may have implications for addressing other diseases. Ribon is supported by notable life science investors, which enhances its capacity to advance its therapeutic developments.

Merlin Labs, established in 2018 and based in Boston, Massachusetts, is dedicated to developing autonomous flight technology for fixed-wing aircraft. The company's core product is an AI-powered aircraft autonomy system, akin to those used in driverless cars, designed to enable safe, unmanned transportation of goods and eventually people. Merlin Labs operates at the intersection of software, transportation, and information technology sectors.

Dyno Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing adeno-associated virus (AAV) vectors for gene therapy applications. Its innovative platform utilizes artificial intelligence, next-generation DNA synthesis, and high-throughput sequencing to design and optimize AAV capsids, which are crucial for delivering therapeutic genes effectively and safely. By leveraging machine learning and quantitative experimentation, Dyno Therapeutics aims to revolutionize the design of gene vectors, focusing on enhancing cell-targeting capabilities. The company's approach seeks to advance the field of gene therapy, making it possible for researchers to access novel AAV vectors that can facilitate more efficient in vivo delivery of new treatments.

Affinia Therapeutics Inc. is a biotechnology company focused on developing gene therapies for the treatment of severe diseases affecting the muscle and central nervous system (CNS). Established in 2019 and based in Waltham, Massachusetts, the company specializes in creating adeno-associated virus (AAV) vectors and utilizes a platform that integrates synthetic and systems biology with high-throughput screening techniques. This innovative approach allows Affinia Therapeutics to design novel gene therapies with enhanced properties tailored to address significant unmet medical needs. The company aims to provide healthcare professionals with advanced therapeutic options for patients suffering from debilitating conditions.

Tend is a modern dental practice that aims to transform the patient experience in oral healthcare. Founded in October 2019, the company operates 25 locations across major cities such as New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on providing hassle-free, personalized, and straightforward dental services, prioritizing patient satisfaction in a calm and inviting environment. By integrating technology with a hospitality-driven approach, Tend seeks to enhance the efficiency and comfort of dental visits. With a team of over 650 professionals, the practice has quickly gained recognition as one of the country's top-rated full-service dental providers, setting a new standard in the industry.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Verve Therapeutics is a genetic medicines company based in Cambridge, Massachusetts, focused on innovative therapies for cardiovascular disease. Founded in 2018, the company aims to transform the management of cardiovascular conditions from chronic treatments to single-course gene editing medicines. Verve Therapeutics employs advanced gene-editing technology and human genetic analysis to develop targeted therapies that reduce the risk of coronary artery diseases. Its initial programs focus on the PCSK9 and ANGPTL3 genes, which are crucial for lowering harmful blood lipids like low-density lipoprotein cholesterol. The company collaborates with strategic partners, including Beam Therapeutics for delivery technologies and Verily for gene editing delivery vehicles, enhancing its capabilities in the biotechnology and healthcare sectors.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Tend is a modern dental practice that aims to transform the patient experience in oral healthcare. Founded in October 2019, the company operates 25 locations across major cities such as New York, Washington DC, Boston, Atlanta, Nashville, and Connecticut. Tend focuses on providing hassle-free, personalized, and straightforward dental services, prioritizing patient satisfaction in a calm and inviting environment. By integrating technology with a hospitality-driven approach, Tend seeks to enhance the efficiency and comfort of dental visits. With a team of over 650 professionals, the practice has quickly gained recognition as one of the country's top-rated full-service dental providers, setting a new standard in the industry.

Sana Biotechnology, Inc. is a biotechnology company focused on developing engineered cells as therapies to treat a wide range of diseases. Established in 2018 and headquartered in Seattle, Washington, with additional offices in South San Francisco and Cambridge, the company utilizes advanced scientific techniques to reprogram cells or replace damaged cells and tissues. This innovative approach aims to create a new class of medicines that address unmet treatment needs across various therapeutic areas, including oncology, diabetes, autoimmune disorders, and central nervous system conditions. Sana's pipeline includes several product candidates designed to provide meaningful medical solutions and transform disease treatment methodologies.

Verve Therapeutics is a genetic medicines company based in Cambridge, Massachusetts, focused on innovative therapies for cardiovascular disease. Founded in 2018, the company aims to transform the management of cardiovascular conditions from chronic treatments to single-course gene editing medicines. Verve Therapeutics employs advanced gene-editing technology and human genetic analysis to develop targeted therapies that reduce the risk of coronary artery diseases. Its initial programs focus on the PCSK9 and ANGPTL3 genes, which are crucial for lowering harmful blood lipids like low-density lipoprotein cholesterol. The company collaborates with strategic partners, including Beam Therapeutics for delivery technologies and Verily for gene editing delivery vehicles, enhancing its capabilities in the biotechnology and healthcare sectors.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Cerevance LLC is a biotechnology company focused on developing innovative therapeutics for neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Founded in 2016 and headquartered in Boston, Massachusetts, with a branch in Cambridge, United Kingdom, Cerevance utilizes its NETSseq platform to profile specific brain cell types, including neurons and glial cells, within mature human brain tissue. By leveraging a substantial repository of over 15,000 human brain samples, the company generates extensive expression and epigenetic data, guiding the identification of promising therapeutic targets. This approach aims to address the early onset of central nervous system diseases by revealing critical transcriptional and epigenetic differences within affected brain regions.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Verve Therapeutics is a genetic medicines company based in Cambridge, Massachusetts, focused on innovative therapies for cardiovascular disease. Founded in 2018, the company aims to transform the management of cardiovascular conditions from chronic treatments to single-course gene editing medicines. Verve Therapeutics employs advanced gene-editing technology and human genetic analysis to develop targeted therapies that reduce the risk of coronary artery diseases. Its initial programs focus on the PCSK9 and ANGPTL3 genes, which are crucial for lowering harmful blood lipids like low-density lipoprotein cholesterol. The company collaborates with strategic partners, including Beam Therapeutics for delivery technologies and Verily for gene editing delivery vehicles, enhancing its capabilities in the biotechnology and healthcare sectors.

Arrakis Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, that specializes in drug discovery focused on ribonucleic acid (RNA) targets. Established in 2015, the company utilizes a proprietary platform that combines advanced RNA bioinformatics, structural tools, and chemical libraries to identify new RNA targets and develop RNA-targeted small molecules (rSMs). This innovative approach aims to address various diseases, including cancer, neurological disorders, and rare genetic conditions. Arrakis also offers SHAPEware, a software tool designed to analyze and predict RNA secondary structures and potential ligand-binding sites, further enhancing its drug development capabilities. Through its comprehensive pipeline, Arrakis Therapeutics seeks to improve treatment options and outcomes for patients across multiple therapeutic areas.

Lola Travel Company, Inc. specializes in corporate travel management through its AI-driven platform, Lola.com. Established in 2015 and headquartered in Boston, Massachusetts, the company simplifies the travel booking process for businesses by offering an intuitive tool for flight and hotel reservations. Lola.com allows users to manage itineraries via a mobile application, providing individual travel profiles, digital travel receipts, and budget tracking services. The platform also supports employee-friendly travel policies, efficient spend reporting for managers, and features that enable team destination sharing and loyalty point accumulation. With 24/7 agent assistance and capabilities for executive assistants to book travel on behalf of others, Lola.com caters to the needs of both employers and business travelers, streamlining the overall travel experience.

Beam Therapeutics Inc. is a biotechnology company based in Cambridge, Massachusetts, specializing in the development of precision genetic medicines utilizing its innovative base editing technology. Founded in 2017, the company aims to provide lifelong cures for patients suffering from serious diseases by targeting specific bases in the genome without inducing double-stranded breaks in DNA. Beam Therapeutics is actively developing therapies for a range of conditions, including sickle cell disease, beta-thalassemia, pediatric T-cell acute lymphoblastic leukemia, pediatric acute myeloid leukemia, alpha-1 antitrypsin deficiency, glycogen storage disorder type 1A, as well as ocular and central nervous system disorders. The company’s diverse pipeline includes several programs such as BEAM-101, BEAM-201, BEAM-301, BEAM-302, and ESCAPE, reflecting its commitment to advancing gene correction, gene modification, gene activation, gene silencing, and multiplex editing technologies.

Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process. The company employs a novel allosteric drug-discovery platform, known as Dynamo, which integrates advanced computational techniques with experimental methods to study protein motion and interactions. This innovative approach enables the identification and development of therapies targeting complex diseases, particularly in oncology. Relay Therapeutics is advancing a pipeline of product candidates, including RLY-1971, a small molecule inhibitor targeting SHP2, RLY-4008, a selective inhibitor of FGFR2 for advanced solid tumors, and RLY-PI3K1047, aimed at mutant variants of phosphoinositide 3-kinase alpha. Founded in 2015, the company aims to deliver life-changing therapies to patients by addressing previously intractable targets in precision oncology and genetic diseases.

RightHand Robotics, Inc. is a manufacturer of robotic order-picking systems that streamline supply chain logistics for various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company specializes in robotic solutions that automatically grasp a wide variety of items from bins and cases. Its flagship products include the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor designed to enhance the robots' ability to handle items gently and correct errors. RightHand Robotics focuses on providing end-to-end solutions that simplify integration and adaptation to diverse customer workflows, ultimately reducing the costs associated with order fulfillment across sectors such as electronics, apparel, grocery, and pharmaceuticals.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

mabl Inc. is an intelligent test automation company based in Boston, Massachusetts, that specializes in providing automated testing services to software development teams. Founded in 2016, mabl focuses on integrating automated end-to-end testing within the continuous integration and continuous delivery (CI/CD) development lifecycle. The company's platform employs machine learning to automatically fix broken tests and identify regressions, offering features such as scriptless testing, test auto-healing, and machine-driven regression testing. By enabling faster and more reliable testing, mabl helps organizations enhance the quality of their applications and accelerate their innovation processes. Its unified platform allows users to create, execute, and maintain tests efficiently, ultimately supporting agile and DevOps methodologies.

Yesware, Inc. is a technology company that specializes in developing a prescriptive sales platform tailored for startups and sales professionals globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within email platforms such as Outlook and Gmail. This toolkit enables sales professionals to track emails, schedule communications, set reminders, and place calls directly from their inboxes. Yesware's platform is designed to enhance sales productivity by providing advanced analytics, customizable email templates, and integration with customer relationship management systems. It supports both small businesses and large enterprises, helping organizations streamline their sales processes and improve customer engagement. Yesware is trusted by companies like Yelp, Twitter, and Monday.com, and has been installed over 1.2 million times, demonstrating its widespread adoption in the sales industry.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Tamr, Inc. is an enterprise data unification company that specializes in developing solutions for data integration and management. Founded in 2013 by industry veterans, the company offers a platform that combines machine learning with human insight to effectively identify and connect diverse internal and external data sources. This technology allows organizations to curate siloed data at scale, generating valuable insights for various business applications. Tamr's offerings include enterprise data preparation software, clinical data conversion, procurement optimization, and customer data integration, catering to industries such as financial services, life sciences, government, and telecommunications. With its headquarters in Cambridge, Massachusetts, Tamr also maintains offices in major U.S. cities and London, reflecting its commitment to delivering innovative data solutions to a broad range of clients.

Openbay, Inc. is a technology company based in Cambridge, Massachusetts, specializing in software solutions for the automotive care industry. Founded in 2011, Openbay operates an online marketplace that connects vehicle owners with a diverse range of automotive service providers, including car dealerships, national chains, independent shops, and mobile mechanics. The platform allows users to find, compare, and book various vehicle repair and maintenance services, such as oil changes, battery replacements, brake services, and more. By streamlining the process of locating and transacting with automotive professionals, Openbay aims to enhance convenience and transparency for consumers seeking automotive care. The company has received recognition for its innovative approach, positioning itself as a trusted resource in the automotive services marketplace.

Celsius Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for patients suffering from cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a multidisciplinary approach, integrating the expertise of scientists, computational biologists, and clinicians. Celsius Therapeutics utilizes advanced techniques such as single-cell genomic analysis and machine learning to identify and develop innovative therapeutic solutions. By leveraging these cutting-edge technologies, the company aims to create life-changing medicines that address unmet medical needs.

SingleStore, Inc. is a provider of a relational database designed for cloud and on-premises transactions and analytics, catering to global enterprises. Founded in 2011 and headquartered in San Francisco, California, the company offers the SingleStore Managed Service, a cloud database-as-a-service that enables analytics on various cloud platforms, alongside SingleStore DB, a distributed SQL database suitable for both bare metal and hybrid cloud environments. The company focuses on operational analytics and supports modern data platform solutions that encompass IoT analytics, risk management, and customer engagement. SingleStore serves a diverse range of industries, including financial services, media communications, energy and utilities, government, and retail. The company, previously known as MemSQL Inc., rebranded to SingleStore, Inc. in October 2020 and also maintains offices in Seattle, Boston, Portland, Lisbon, and London.

Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming the drug discovery process. The company employs a novel allosteric drug-discovery platform, known as Dynamo, which integrates advanced computational techniques with experimental methods to study protein motion and interactions. This innovative approach enables the identification and development of therapies targeting complex diseases, particularly in oncology. Relay Therapeutics is advancing a pipeline of product candidates, including RLY-1971, a small molecule inhibitor targeting SHP2, RLY-4008, a selective inhibitor of FGFR2 for advanced solid tumors, and RLY-PI3K1047, aimed at mutant variants of phosphoinositide 3-kinase alpha. Founded in 2015, the company aims to deliver life-changing therapies to patients by addressing previously intractable targets in precision oncology and genetic diseases.

Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

Toast, Inc. is a Boston-based restaurant technology company that specializes in developing an all-in-one point-of-sale and restaurant management platform tailored for the food service and hospitality industries. Founded in 2011, Toast offers a cloud-based system designed specifically for restaurants, enabling functionalities such as tableside ordering, real-time reporting, online ordering, and labor management. The platform serves a diverse clientele, including restaurants, cafés, bars, and bakeries, and supports over 120,000 locations across the United States. Toast generates revenue through software subscription fees, transaction processing commissions, and additional services such as hardware installation and professional support. By facilitating payment transactions on its platform, Toast processed approximately $126 billion in gross volume in 2023, demonstrating its significant role in the restaurant technology landscape.

Evelo Biosciences, Inc., established in 2015, is a biotechnology company based in Cambridge, Massachusetts. It specializes in the discovery and development of a novel class of medicines known as monoclonal microbials, which are orally delivered and designed to modulate systemic immunology and biology by interacting with human cells in the gut. Evelo's pipeline includes EDP1815, currently in a Phase 1b clinical trial for psoriasis and atopic dermatitis, and EDP1503, in a Phase 1/2 study for various cancer types, including colorectal, triple-negative breast, and melanoma. The company aims to apply this innovative approach across a broad range of diseases, including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory conditions, and cancer.

Compass Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative antibody therapeutics for the treatment of solid tumors and hematological malignancies. Founded in 2014 and headquartered in Cambridge, Massachusetts, the company utilizes its proprietary StitchMabs and common light-chain platforms to discover and create multispecific antibody combinations. Its lead product candidate, CTX-471, is an agonistic monoclonal antibody targeting CD137, currently undergoing Phase 1 clinical trials in patients with prior PD-1/PD-L1 checkpoint inhibitor treatment. Another significant candidate, CTX-009, is a bispecific antibody that inhibits DLL4-mediated Notch signaling and VEGF-A signaling, having completed a Phase 1 dose escalation study. Additionally, CTX-8371, a bispecific antibody targeting PD-1 and PD-L1, is in the IND-enabling stage. Through its innovative approaches, Compass Therapeutics aims to enhance immune engagement and improve therapeutic outcomes for cancer patients.

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing novel therapies for patients with genetically defined diseases that have significant unmet medical needs. The company's lead product candidate, losmapimod, is a small molecule currently undergoing Phase 2b clinical trials for the treatment of facioscapulohumeral muscular dystrophy, a rare condition characterized by progressive muscle wasting and disability. Another key candidate, FTX-6058, aims to upregulate fetal hemoglobin to treat sickle cell disease and beta-thalassemia. Fulcrum is also actively researching drug targets for other genetic disorders, including Duchenne muscular dystrophy and Friedreich ataxia, as well as neurological and pulmonary diseases. The company has established collaborations with Acceleron Pharma to explore biological targets in pulmonary disease and with MyoKardia to develop therapies for genetic cardiomyopathies. Founded in 2015, Fulcrum Therapeutics continues to focus on improving patient outcomes in rare disease contexts.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on advancing stem cell transplantation and related therapies. Founded in 2015, the company aims to enhance the patient experience in transplant medicine by developing innovative treatments that make stem cell transplants safer and more accessible. Its pipeline includes several key candidates, such as C100, C200, and C300 targeted antibody-drug conjugates designed for transplant conditioning; MGTA-145, a stem cell mobilization product; and MGTA-456, an allogeneic stem cell therapy. Additionally, Magenta is exploring E478, a small molecule aimed at expanding gene-modified stem cells, and G100, an antibody-drug conjugate to mitigate acute graft-versus-host disease. The company has established research collaborations with other biotechnology firms to further investigate the potential of its therapies in treating blood cancers, genetic disorders, and autoimmune diseases, ultimately striving to transform stem cell transplantation from a last-resort option into a more viable and effective treatment for patients.

Arsanis, Inc. is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, specializing in monoclonal antibody (mAb) immunotherapies for serious infectious diseases. Founded in 2010, Arsanis focuses on developing innovative therapies targeting various bacterial and viral pathogens. Its lead clinical program, ASN100, is currently in a Phase 2 trial aimed at preventing Staphylococcus aureus pneumonia in high-risk, mechanically ventilated patients. The company's preclinical pipeline includes mAbs directed against respiratory syncytial virus and Gram-negative bacteria, such as Klebsiella pneumoniae and Escherichia coli. Arsanis leverages advanced mAb discovery techniques to create a diverse range of therapeutic candidates with multiple mechanisms of action, addressing the urgent need for effective treatments in infectious disease management. The company also has research and preclinical development operations in Vienna, Austria, under Arsanis Biosciences GmbH.

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases. Founded in 2013, the company is advancing several product candidates, including tebipenem pivoxil hydrobromide, an oral carbapenem-class antibiotic aimed at treating MDR gram-negative infections in adults. Additionally, Spero is developing SPR206, an intravenous agent for MDR gram-negative infections in hospital settings, and SPR720, an oral antibiotic targeting pulmonary non-tuberculous mycobacterial disease. The company collaborates with various partners, including Meiji Seika Pharma to support tebipenem HBr's development and the Bill & Melinda Gates Medical Research Institute for SPR720. Spero Therapeutics employs a focused approach to drug development, emphasizing novel mechanisms to address the urgent need for effective therapeutics against serious bacterial infections.

Desktop Metal, Inc. is a manufacturer of additive manufacturing solutions, specializing in 3D printing technologies for metal and carbon fiber. Founded in 2015 and headquartered in Burlington, Massachusetts, the company offers a range of products, including the Production System for industrial manufacturing, the Shop System for machine and job shops, the Studio System designed for office use, and the Fiber desktop 3D printer. Desktop Metal serves a variety of industries such as automotive, aerospace, healthcare, consumer products, heavy industry, machine design, and research and development. Its innovative systems, materials, and software facilitate on-demand digital mass production, providing the speed, cost-efficiency, and part quality necessary for modern manufacturing. The company markets its solutions across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region, with a significant portion of its revenue generated from the Americas.

Lola Travel Company, Inc. specializes in corporate travel management through its AI-driven platform, Lola.com. Established in 2015 and headquartered in Boston, Massachusetts, the company simplifies the travel booking process for businesses by offering an intuitive tool for flight and hotel reservations. Lola.com allows users to manage itineraries via a mobile application, providing individual travel profiles, digital travel receipts, and budget tracking services. The platform also supports employee-friendly travel policies, efficient spend reporting for managers, and features that enable team destination sharing and loyalty point accumulation. With 24/7 agent assistance and capabilities for executive assistants to book travel on behalf of others, Lola.com caters to the needs of both employers and business travelers, streamlining the overall travel experience.

Qwiklabs Inc. is a company that specializes in providing virtual lab environments for software training, enabling developers and IT professionals to gain hands-on experience with cloud technologies, particularly those associated with AWS. Founded in 2012 and headquartered in Carlisle, Massachusetts, Qwiklabs offers a platform that allows clients to create, manage, and operate labs for various applications, including security, big data, and serverless web apps. The platform features a wide array of self-paced labs and AWS-authorized instructor-led training courses, ensuring learners can access real-world scenarios in actual AWS environments. Qwiklabs also provides a flexible pricing model, allowing users to access specific labs or opt for an all-inclusive subscription. Additionally, learners can earn badges and complete quests to enhance their knowledge and credentials in key areas such as AWS Certification Exam preparation and advanced operations. As of November 2016, Qwiklabs operates as a subsidiary of Alphabet Inc.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Toast, Inc. is a Boston-based restaurant technology company that specializes in developing an all-in-one point-of-sale and restaurant management platform tailored for the food service and hospitality industries. Founded in 2011, Toast offers a cloud-based system designed specifically for restaurants, enabling functionalities such as tableside ordering, real-time reporting, online ordering, and labor management. The platform serves a diverse clientele, including restaurants, cafés, bars, and bakeries, and supports over 120,000 locations across the United States. Toast generates revenue through software subscription fees, transaction processing commissions, and additional services such as hardware installation and professional support. By facilitating payment transactions on its platform, Toast processed approximately $126 billion in gross volume in 2023, demonstrating its significant role in the restaurant technology landscape.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Editas Medicine is a clinical-stage biotechnology company based in Cambridge, Massachusetts, with an additional site in Boulder, Colorado. Founded in 2013, the company focuses on the discovery and development of genome editing therapeutics, primarily utilizing its proprietary CRISPR/Cas9 technology. This innovative platform enables precise molecular modifications at the genetic level, with the aim of treating a wide array of serious diseases by addressing their underlying causes. Editas Medicine has established a strong intellectual property portfolio, which includes numerous patents related to foundational genome editing technologies and advancements that facilitate the translation of research into viable human therapeutics. The company's mission is to pioneer transformative genomic medicines that can significantly improve patient outcomes across various genetic disorders.

Panorama Education, Inc. is a data analytics company based in Boston, Massachusetts, that focuses on K-12 education. Founded in 2012, the company provides a software-as-a-service (SaaS) platform that enables school districts, charter networks, and state governments to conduct comprehensive surveys of students, parents, teachers, and staff. Through its research-based surveys, Panorama collects valuable feedback on various aspects of the educational environment, including teacher performance and school climate. The platform generates detailed reports that allow educators and administrators to analyze results across different demographics. Additionally, Panorama offers implementation consultation, technical assistance, and training to enhance the effectiveness of its services. By leveraging stakeholder feedback, the company aims to support professional development and improve student outcomes in schools.

Tamr, Inc. is an enterprise data unification company that specializes in developing solutions for data integration and management. Founded in 2013 by industry veterans, the company offers a platform that combines machine learning with human insight to effectively identify and connect diverse internal and external data sources. This technology allows organizations to curate siloed data at scale, generating valuable insights for various business applications. Tamr's offerings include enterprise data preparation software, clinical data conversion, procurement optimization, and customer data integration, catering to industries such as financial services, life sciences, government, and telecommunications. With its headquarters in Cambridge, Massachusetts, Tamr also maintains offices in major U.S. cities and London, reflecting its commitment to delivering innovative data solutions to a broad range of clients.

Yesware, Inc. is a technology company that specializes in developing a prescriptive sales platform tailored for startups and sales professionals globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within email platforms such as Outlook and Gmail. This toolkit enables sales professionals to track emails, schedule communications, set reminders, and place calls directly from their inboxes. Yesware's platform is designed to enhance sales productivity by providing advanced analytics, customizable email templates, and integration with customer relationship management systems. It supports both small businesses and large enterprises, helping organizations streamline their sales processes and improve customer engagement. Yesware is trusted by companies like Yelp, Twitter, and Monday.com, and has been installed over 1.2 million times, demonstrating its widespread adoption in the sales industry.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Recorded Future, Inc. is a threat intelligence company that provides real-time solutions to enhance cybersecurity for organizations. Founded in 2009 and headquartered in Somerville, Massachusetts, with additional offices in McLean, Virginia, and Gothenburg, Sweden, the company leverages patented machine learning technology to analyze data from the open web, dark web, and technical sources. This enables organizations to gain comprehensive insights into potential threats and vulnerabilities, facilitating swift and informed decision-making. Its offerings include tools for threat intelligence teams and security operation center (SOC) teams, as well as specialized services like dark web monitoring, executive cyber protection, and custom intelligence assessments. Additionally, Recorded Future provides integration services that streamline workflows and enhance operational capabilities through real-time alerts and monitoring dashboards. The company’s platform empowers users to respond to security threats more effectively, thereby reducing risks associated with cyberattacks.

Adelphic, Inc. is a company that specializes in developing a mobile and cross-channel programmatic advertising platform aimed at connecting brands with audiences. Founded in 2011 and based in Waltham, Massachusetts, Adelphic offers a self-service software solution that allows non-technical users to manage advertising campaigns effectively. Its platform is designed to facilitate meaningful engagements with consumers across various devices and formats, utilizing real-time bidding capabilities to ensure global reach. Key features of the platform include a campaign management portal, Audience Cube for data segmentation and insights, and predictive performance engine solutions. Adelphic primarily serves agencies, brands, and large media buyers, enabling them to overcome user identification limitations in digital advertising by providing rich, detailed profiles of consumers. As of early 2017, Adelphic operates as a subsidiary of Viant Technology Inc.

Tamr, Inc. is an enterprise data unification company that specializes in developing solutions for data integration and management. Founded in 2013 by industry veterans, the company offers a platform that combines machine learning with human insight to effectively identify and connect diverse internal and external data sources. This technology allows organizations to curate siloed data at scale, generating valuable insights for various business applications. Tamr's offerings include enterprise data preparation software, clinical data conversion, procurement optimization, and customer data integration, catering to industries such as financial services, life sciences, government, and telecommunications. With its headquarters in Cambridge, Massachusetts, Tamr also maintains offices in major U.S. cities and London, reflecting its commitment to delivering innovative data solutions to a broad range of clients.

Kensho Technologies, Inc. is a provider of advanced analytics, artificial intelligence, machine learning, and data visualization systems tailored for global banks and investment institutions. The company develops Kensho Financial Analytics Software, which delivers scalable analytical solutions to enhance decision-making within commercial entities. Kensho's offerings also include the Kensho Applied Mind, a sophisticated AI software that enables natural language processing to address complex financial inquiries in plain English. Additionally, Kensho operates a national security division known as Koto. Founded in 2012 and headquartered in Cambridge, Massachusetts, Kensho has expanded its presence with offices in New York, McLean, and Pacific Palisades. As of April 2018, Kensho Technologies operates as a subsidiary of S&P Global Inc.

Boston Dynamics, Inc. is an engineering company based in Waltham, Massachusetts, specializing in the design and manufacture of advanced robots and software for human simulation. Founded in 1992 as a spin-off from the Massachusetts Institute of Technology, the company has gained recognition for its innovative robots that mimic animal movement, such as Spot, a quadruped robot, and Atlas, a humanoid robot. These robots are equipped with cutting-edge mobility, dexterity, and intelligence, allowing them to perform tasks in challenging environments, including industrial plants, construction sites, and warehouses. Boston Dynamics also develops software for human simulation, which is utilized in various training applications, including law enforcement and military operations. The company collaborates with organizations globally, providing solutions to some of the most complex challenges in automation and robotics.

Yesware, Inc. is a technology company that specializes in developing a prescriptive sales platform tailored for startups and sales professionals globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within email platforms such as Outlook and Gmail. This toolkit enables sales professionals to track emails, schedule communications, set reminders, and place calls directly from their inboxes. Yesware's platform is designed to enhance sales productivity by providing advanced analytics, customizable email templates, and integration with customer relationship management systems. It supports both small businesses and large enterprises, helping organizations streamline their sales processes and improve customer engagement. Yesware is trusted by companies like Yelp, Twitter, and Monday.com, and has been installed over 1.2 million times, demonstrating its widespread adoption in the sales industry.

Openbay, Inc. is a technology company based in Cambridge, Massachusetts, specializing in software solutions for the automotive care industry. Founded in 2011, Openbay operates an online marketplace that connects vehicle owners with a diverse range of automotive service providers, including car dealerships, national chains, independent shops, and mobile mechanics. The platform allows users to find, compare, and book various vehicle repair and maintenance services, such as oil changes, battery replacements, brake services, and more. By streamlining the process of locating and transacting with automotive professionals, Openbay aims to enhance convenience and transparency for consumers seeking automotive care. The company has received recognition for its innovative approach, positioning itself as a trusted resource in the automotive services marketplace.

Yesware, Inc. is a technology company that specializes in developing a prescriptive sales platform tailored for startups and sales professionals globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within email platforms such as Outlook and Gmail. This toolkit enables sales professionals to track emails, schedule communications, set reminders, and place calls directly from their inboxes. Yesware's platform is designed to enhance sales productivity by providing advanced analytics, customizable email templates, and integration with customer relationship management systems. It supports both small businesses and large enterprises, helping organizations streamline their sales processes and improve customer engagement. Yesware is trusted by companies like Yelp, Twitter, and Monday.com, and has been installed over 1.2 million times, demonstrating its widespread adoption in the sales industry.

SynapDx is a diagnostic company based in Lexington, Massachusetts, focused on providing laboratory testing services aimed at the early detection of autism spectrum disorders (ASDs) in children. Established by Stanley Lapidus, the company develops blood-based diagnostic tests that leverage insights from experts in ASD and gene expression. These tests are designed to assist healthcare providers in identifying early symptoms of autism, addressing the need for timely intervention in a condition that affects approximately 1 in 110 children in the United States. Through its innovative approach, SynapDx aims to enhance the diagnostic process for developmental disorders and improve outcomes for affected children and their families.

Objective Logistics, Inc. is a provider of an artificial intelligence-driven, web-based labor management platform tailored for the retail and hospitality industries. Founded in 2009 and headquartered in Boston, Massachusetts, the company offers MUSE, a software solution designed to motivate, measure, and mentor staff by evaluating performance through customizable metrics such as sales figures and behavior. MUSE incorporates features like custom contests, leaderboards, and analytics reports, which enhance team motivation and provide valuable insights into both individual and overall location performance. Additionally, the platform includes staff scheduling and forecasting tools, enabling managers to align their teams with organizational objectives. The company aims to lift sales and improve the guest experience across various sectors.

Adelphic, Inc. is a company that specializes in developing a mobile and cross-channel programmatic advertising platform aimed at connecting brands with audiences. Founded in 2011 and based in Waltham, Massachusetts, Adelphic offers a self-service software solution that allows non-technical users to manage advertising campaigns effectively. Its platform is designed to facilitate meaningful engagements with consumers across various devices and formats, utilizing real-time bidding capabilities to ensure global reach. Key features of the platform include a campaign management portal, Audience Cube for data segmentation and insights, and predictive performance engine solutions. Adelphic primarily serves agencies, brands, and large media buyers, enabling them to overcome user identification limitations in digital advertising by providing rich, detailed profiles of consumers. As of early 2017, Adelphic operates as a subsidiary of Viant Technology Inc.

HubSpot, Inc., established in 2005 and headquartered in Cambridge, Massachusetts, specializes in providing a comprehensive, cloud-based software platform for businesses worldwide. This platform integrates marketing, sales, and customer service applications, including CRM, SEO, content management, messaging, marketing automation, analytics, and more. HubSpot serves mid-market business-to-business companies, helping them attract visitors, convert leads, and close customers through its inbound marketing approach.

Foundation Medicine, Inc. is a biotechnology company based in Cambridge, Massachusetts, that specializes in providing molecular information products for cancer diagnosis and treatment. The company utilizes advanced genomic profiling technologies to analyze tumor specimens, enabling healthcare providers to gain insights into individual patients' cancer profiles. This information assists in optimizing treatment strategies, particularly for targeted therapies and immunotherapies. Foundation Medicine’s product offerings include FoundationOne for solid tumors, FoundationOne Heme for blood-based cancers, and various diagnostic assays to support clinical decision-making in oncology. The company also maintains a knowledgebase, FoundationCORE, to disseminate scientific advancements and strengthen collaborations within the oncology community. Foundation Medicine has established strategic partnerships with major pharmaceutical companies and research organizations to enhance precision medicine initiatives and develop companion diagnostics for specific therapies. Founded in 2009, Foundation Medicine operates as a subsidiary of Roche Holdings, Inc.

Objective Logistics, Inc. is a provider of an artificial intelligence-driven, web-based labor management platform tailored for the retail and hospitality industries. Founded in 2009 and headquartered in Boston, Massachusetts, the company offers MUSE, a software solution designed to motivate, measure, and mentor staff by evaluating performance through customizable metrics such as sales figures and behavior. MUSE incorporates features like custom contests, leaderboards, and analytics reports, which enhance team motivation and provide valuable insights into both individual and overall location performance. Additionally, the platform includes staff scheduling and forecasting tools, enabling managers to align their teams with organizational objectives. The company aims to lift sales and improve the guest experience across various sectors.

Yesware, Inc. is a technology company that specializes in developing a prescriptive sales platform tailored for startups and sales professionals globally. Founded in 2010 and headquartered in Boston, Massachusetts, with an additional office in San Francisco, Yesware offers an all-in-one toolkit for sales within email platforms such as Outlook and Gmail. This toolkit enables sales professionals to track emails, schedule communications, set reminders, and place calls directly from their inboxes. Yesware's platform is designed to enhance sales productivity by providing advanced analytics, customizable email templates, and integration with customer relationship management systems. It supports both small businesses and large enterprises, helping organizations streamline their sales processes and improve customer engagement. Yesware is trusted by companies like Yelp, Twitter, and Monday.com, and has been installed over 1.2 million times, demonstrating its widespread adoption in the sales industry.

Triptrotting, Inc. is an innovative travel company that connects travelers with local hosts, specifically catering to university students, alumni, and young professionals. Founded in 2009 and headquartered in Pasadena, California, Triptrotting operates an online community that matches users based on shared interests. Its application, "Wist," enhances the travel experience by allowing users to immerse themselves in local cultures, whether exploring their own city or visiting a new destination. By leveraging contextual, personalized, and social data, Triptrotting provides tailored recommendations that help users navigate unfamiliar environments with ease. The company also maintains additional offices in major cities including New York, Los Angeles, Miami, Washington D.C., Boston, and Chicago, further expanding its reach in the travel industry.